# Quva Pharma, Inc.

Canonical: https://abierto.us/vendors/quva-pharma-inc-muabdczxmlg4

- UEI: MUABDCZXMLG4
- CAGE: 7VLA4
- Parent: Quva Pharma Inc.
- Location: Sugar Land, TX
- Awards in window: 9 (12 transactions), $220,893 obligated, April 17, 2024 to May 29, 2026

## Awarding agencies

- National Institutes of Health: 8 awards, $423,682
- Department of the Army: 1 awards, -$202,789

## Industries

- 325412 Pharmaceutical Preparation Manufacturing: $220,893

## Competition

- Competed Under SAP: 6 awards
- Not Competed Under SAP: 3 awards

## Solicitations won

- Notice of Intent to Sole Source; Monument Medical (25-000116). https://abierto.us/opportunities/25000116

## Largest awards

- 75N90024F00001 (delivery order): $250,000, National Institutes of Health - CC. Outsourcing Pcas and Epidurals. https://www.usaspending.gov/award/CONT_AWD_75N90024F00001_7529_75N90019D00030_7529/
- 75N98026P00592 (purchase order): $110,000, National Institutes of Health Olao. Outsourcing Pcas and Epidurals for Patients Care from Quva Pharma, INC.. https://www.usaspending.gov/award/CONT_AWD_75N98026P00592_7529_-NONE-_-NONE-/
- 75N90025P00194 (purchase order): $100,000, National Institutes of Health - CC. Pharmaceuticals Quva Pharma, INC.:1327585 [25-000116]. https://www.usaspending.gov/award/CONT_AWD_75N90025P00194_7529_-NONE-_-NONE-/
- 75N90025P00053 (purchase order): $25,000, National Institutes of Health - CC. IV Medications Quva Pharma, INC.:1327585 [25-000665]. https://www.usaspending.gov/award/CONT_AWD_75N90025P00053_7529_-NONE-_-NONE-/
- 75N90019D00030: $0, National Institutes of Health - CC. Sterile Compounding 503B Facility Quva Pharma, INC.:1327585. https://www.usaspending.gov/award/CONT_IDV_75N90019D00030_7529/
- 75N90025D00001: $0, National Institutes of Health - CC. Non Patient-Specific Sterile Compounded Pharmaceutical Products for Patients in the NIH CC on an as Called in Basis.. https://www.usaspending.gov/award/CONT_IDV_75N90025D00001_7529/
- 75N90019F00043 (delivery order): -$6,988, National Institutes of Health - CC. Quva Pharma, INC.:1327585 [19-017387]. https://www.usaspending.gov/award/CONT_AWD_75N90019F00043_7529_75N90019D00030_7529/
- 75N90020F00001 (delivery order): -$54,330, National Institutes of Health - CC. To Administratively De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation for September 30, 2026, Closing of the Period of Availability of These Fiscal Year Funds.. https://www.usaspending.gov/award/CONT_AWD_75N90020F00001_7529_75N90019D00030_7529/
- W81K0019P0334 (purchase order): -$202,789, W40M MRC0 West. Pharmaceuticals to Include Succinylcholine 20mg/Ml. https://www.usaspending.gov/award/CONT_AWD_W81K0019P0334_9700_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/quva-pharma-inc-muabdczxmlg4.